President Joe Biden reportedly will take executive action to reopen federal marketplaces selling Affordable Care Act (ACA) health plans; Moderna investigating booster shot designed to be more effective against emerging variants of coronavirus disease 2019 (COVID-19); Brazil coronavirus variant is found in Minnesota.
This week, President Joe Biden plans to take executive action on health insurance as he moves to reopen federal marketplaces selling Affordable Care Act (ACA) health plans and lower barriers to joining Medicaid, according to a report Tuesday in The Washington Post. Citing individuals inside and outside the administration, the effort is aimed at assisting Americans who lost their health insurance as a result of job losses or other factors stemming from the coronavirus disease 2019 (COVID-19) pandemic. Typically, open enrollment would not occur until a restricted 6-week period at the end of the year.
Moderna said it plans to manufacture a COVID-19 booster shot designed to be more effective against emerging variants of the coronavirus amid reports that their approved vaccine is less potent against the variant identified in South Africa. Moderna will test 2 booster-shot options, with 1 targeting the South African variant and the other to fight new mutations. Notably, the company’s approved vaccine showed no reduction in producing neutralizing antibodies against the more contagious, and potentially more lethal, variant discovered in the United Kingdom.
Reported by The Associated Press, the first US-reported case of the novel coronavirus variant identified in Brazil was found in an individual who recently returned from the country to Minnesota. The variant, known as P.1, has raised concern among researchers who say that people who have already been infected with COVID-19 may be at risk of being reinfected with the Brazilian variant. Although reinfection is reportedly rare, there is a confirmed case in Brazil of someone with the new variant who had been infected with a different virus strain several months earlier.
Insurance Payer Is Associated With Length of Stay After Traumatic Brain Injury
February 21st 2025Among hospitalized patients with traumatic brain injury, Medicaid fee-for-service was associated with longer hospital stays than private insurance and Medicaid managed care organizations.
Read More
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
NSCLC Advancements Offer Hope, but Disparities Persist
February 20th 2025Ioana Bonta, MD, Georgia Cancer Specialists, discusses the evolving state of non-small cell lung cancer (NSCLC) treatments, their impact on patient outcomes, and the need to address ongoing disparities in these populations.
Read More
Abortion in 2025: Access, Fertility, and Infant Mortality Updates
February 20th 2025While Republican state-led efforts aim to increase restrictions to abortion care and access to mifepristone and misoprostol in 2025, JAMA authors join the conversation with their published research and commentary.
Read More
Adapting ACA Access Amid Medicaid Transition and Policy Reversals: Molly Dean
February 19th 2025As enrollment shifts to the Affordable Care Act (ACA) marketplace following the unwinding of Medicaid and the Trump administration begins to implement health policy changes, Molly Dean, MSW, Siftwell's policy advisor, shares insight on how to adapt.
Read More